Sign in

CIK 0001649989

  • Non-accelerated filer
  • Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
383982704
Phone
+1 609-619-3990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 71 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-19 Sukhtian Faisal Ghiath Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2020-03-19 HILZINGER KURT J Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2020-03-19 Haddadin Yezan Munther Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2020-03-19 THURMAN RANDY H Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2020-02-26 Sukhtian Ghiath M. Director Grant or award +2,460,630 $1.02 $2.5M 2,460,630
2020-02-26 Sukhtian Ghiath M. Director Grant or award · Warrants +1,230,315 $0.13 $154K 1,230,315
2020-01-29 BioLexis Pte Ltd. Director Option exercise +4,657,852 $0.23 $1.1M 21,606,437
2020-01-29 BioLexis Pte Ltd. Director Option exercise · Warrant (Right to Buy) −2,093,750 0
2020-01-29 BioLexis Pte Ltd. Director Option exercise · Warrant (Right to Buy) −1,282,051 $1.00 $1.3M 0
2020-01-29 BioLexis Pte Ltd. Director Option exercise · Warrant (Right to Buy) −1,282,051 $1.00 $1.3M 0
2020-01-27 BioLexis Pte Ltd. Director Returned to the company · Warrant (Right to Buy) −2,093,750 0
2020-01-27 BioLexis Pte Ltd. Director Grant or award · Warrant (Right to Buy) +2,093,750 2,039,750
2020-01-27 BioLexis Pte Ltd. Director Returned to the company · Warrant (Right to Buy) −1,282,051 $1.00 $1.3M 0
2020-01-27 BioLexis Pte Ltd. Director Grant or award · Warrant (Right to Buy) +1,282,051 $1.00 $1.3M 1,282,051
2020-01-27 BioLexis Pte Ltd. Director Returned to the company · Warrant (Right to Buy) −1,282,051 $1.00 $1.3M 0
2020-01-27 BioLexis Pte Ltd. Director Grant or award · Warrant (Right to Buy) +1,282,051 $1.00 $1.3M 1,282,051
2020-01-02 Haddadin Yezan Munther Director Grant or award · Stock Option (Right to Buy) +5,980 $0.99 $6K 5,980
2019-12-31 BioLexis Pte Ltd. Director Other acquisition · Series A-1 Convertible Preferred Stock +1,661 68,112
2019-12-23 BioLexis Pte Ltd. Director Option exercise +2,909,091 $0.23 $675K 16,948,585
2019-12-23 BioLexis Pte Ltd. Director Option exercise · Warrant (Right to Buy) −3,636,364 0

Page 12 of 14 · 276 trades